SubjectWell, the Patient Experience Platform driving predictable clinical trial enrollment and patient retention, has announced that Steve Ciske has joined the organization as Chief Technology Officer. In this role, he will advance the company’s innovation initiatives and AI strategy, as well as ensures security and compliance practices.
Steve brings more than 20 years of technology leadership experience across healthcare, consulting, manufacturing, and private equity collaborations. He is recognized for driving transformative change within organizations, leveraging digital transformation strategies to accelerate product innovation, streamline operations, and boost revenue. Known as a hands-on, “player/coach” executive, Steve combines strategic oversight with direct operational involvement, enabling rapid improvements in team performance and organizational effectiveness.
Also Read: Scipher Medicine Unveils AI Platform to Predict Trial Failure
“Steve’s breadth of experience, from startups to Fortune 50 companies, combined with his proven ability to align technology with business goals, makes him an outstanding addition to our leadership team,” said Fred Martin, CEO of SubjectWell. “His expertise in digital transformation and team leadership will play a pivotal role in enhancing our platform, optimizing patient recruitment, and ultimately enabling us to do more for patients worldwide.”
Before joining SubjectWell, Steve held senior technology leadership roles where he successfully led innovation initiatives, complex turnarounds, and the development of high-performing teams. His specialties include strategic planning, architecture, product acceleration, private equity engagement, and implementing enterprise-level solutions that deliver measurable results.
Source: PRNewswire